about
Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and VinaDeep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and proteaseCoVaMa: Co-Variation Mapper for disequilibrium analysis of mutant loci in viral populations using next-generation sequence data.Identification of broad-based HIV-1 protease inhibitors from combinatorial librariesIdentification of HIV-1 inhibitors targeting the nucleocapsid protein.Analysis of HIV wild-type and mutant structures via in silico docking against diverse ligand libraries.Empirical entropic contributions in computational docking: evaluation in APS reductase complexes.Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling.Rapid deep sequencing of patient-derived HIV with ion semiconductor technology.Accessory mutations maintain stability in drug-resistant HIV-1 protease.Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies.Diurnal transcriptome atlas of a primate across major neural and peripheral tissues.SHMT2 and the BRCC36/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy.Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolismTranscription Elongation Can Affect Genome 3D StructureMHC class II proteins mediate cross-species entry of bat influenza virusesMetascape provides a biologist-oriented resource for the analysis of systems-level datasetsIdentification and dynamic quantification of regulatory elements using total RNATime-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian ClockViral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa CellsApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
P50
Q28475016-77BE3E2F-27E0-4779-97A6-C13C7AFAFB7EQ28546549-26D82C73-F207-4D76-8D44-18724723CFBEQ30997587-69A87DA2-1FCC-457C-84F4-3663779EC09EQ33589171-B0FB6C77-97E2-42AE-B5FE-CF83D0DF3CE8Q34269543-204E54C3-55D0-4F2B-BD7C-0AE8B9E4E941Q34621023-A97C46B6-8515-470F-B1C3-26BA12939547Q34640060-0121DA58-1303-4605-B605-1E0D63179DFDQ35826946-9E00FE14-8851-482C-A625-EAC3A4755888Q36718188-6CFD92B7-B53D-48F9-8F1C-D942AA17B08DQ42825516-68D4B845-5D68-411E-93D2-985830597010Q47153468-600E0007-DCCF-4054-A5A4-583BE0E96C98Q48147788-C6573D14-45D8-4E6A-8506-30C76BE0DCF3Q50036475-338C90D7-89F5-40BB-A2F9-5384F52229FCQ55285065-B02B2F38-A623-4253-933E-A9C457837F95Q57114440-9FB2E108-6CBD-4C93-B46F-3439B91263A1Q59353868-A0F648C9-700D-401D-BD7F-A008849D76E2Q61795278-4D9ED29C-E6EB-4E3E-8713-632072FA4F1DQ64081579-D2B814EE-195D-469E-B59E-B762E103FE47Q90928415-9E6D68F4-73DF-4E8B-A2E8-7D4C9003803BQ91264718-A84C5214-EEE6-406E-BF26-64CE6B7C90CAQ91496119-ED98775E-9428-47D6-9EC0-58DADD950509Q92050948-06BF4E5F-28B4-4B91-AE61-DC3AE28A6EC2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Max W Chang
@ast
Max W Chang
@en
Max W Chang
@es
Max W Chang
@nl
type
label
Max W Chang
@ast
Max W Chang
@en
Max W Chang
@es
Max W Chang
@nl
prefLabel
Max W Chang
@ast
Max W Chang
@en
Max W Chang
@es
Max W Chang
@nl
P106
P31
P496
0000-0002-4526-489X